| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 55.368 | 360.724 | 631.673 | 645.788 | 705.414 |
| Total Income - EUR | - | - | - | - | - | 55.370 | 363.606 | 633.223 | 646.703 | 705.579 |
| Total Expenses - EUR | - | - | - | - | - | 53.288 | 348.317 | 607.687 | 620.812 | 665.272 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 2.082 | 15.289 | 25.537 | 25.891 | 40.307 |
| Net Profit/Loss - EUR | - | - | - | - | - | 1.528 | 10.012 | 20.224 | 19.114 | 26.421 |
| Employees | - | - | - | - | - | 1 | 4 | 6 | 9 | 8 |
Check the financial reports for the company - Alpen Pharma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 4.655 | 4.691 | 2.916 | 2.926 |
| Current Assets | - | - | - | - | - | 61.878 | 90.931 | 126.691 | 149.624 | 116.966 |
| Inventories | - | - | - | - | - | 8.856 | 6.749 | 1.421 | 2.994 | 3.245 |
| Receivables | - | - | - | - | - | 31.053 | 61.544 | 120.206 | 72.926 | 78.679 |
| Cash | - | - | - | - | - | 21.969 | 22.638 | 5.064 | 73.704 | 35.043 |
| Shareholders Funds | - | - | - | - | - | 53.212 | 62.044 | 82.461 | 101.325 | 92.178 |
| Social Capital | - | - | - | - | - | 51.684 | 50.538 | 50.695 | 50.541 | 50.258 |
| Debts | - | - | - | - | - | 8.666 | 33.702 | 48.921 | 51.564 | 27.954 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7311 - 7311" | |||||||||
| CAEN Financial Year |
7311
|
|||||||||
Comments - Alpen Pharma S.r.l.